Remdesivir treatment does not reduce viral titers in patients with COVID-19

被引：0
|
作者：
Faghihi, Isa [1 ]
Yan, Victoria C. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr, Dallas, TX 75390 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2024年 / 68卷 / 08期
关键词：
remdesivir; SARS-CoV-2; COVID-19; pharmacology; pharmacodynamics; antivirals; drug development;
D O I：
10.1128/aac.00856-24
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The relationship (or lack thereof) between the clinical activity of remdesivir and its ability to reduce viral titers in patients with COVID-19 has not been fully delineated. There is a misconception that remdesivir was FDA-approved for COVID-19 due to its ability to reduce viral titers. Here, we analyze all clinical studies of remedesivir in COVID-19 that quantifed SARS-CoV-2 titers. As of 28 June 2024, we show there is no significant decrease in SARS-CoV-2 viral titers in patients treted with remdesivir compared to placebo controls.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Remdesivir for the Treatment of COVID-19: A Narrative Review
    Patrick O. Godwin
    Bryan Polsonetti
    Michael F. Caron
    Thomas F. Oppelt
    [J]. Infectious Diseases and Therapy, 2024, 13 : 1 - 19
  • [32] Pulmonary administration of remdesivir in the treatment of COVID-19
    Rasmussen, Henrik Berg
    Hansen, Peter Riis
    Taboureau, Olivier
    Thomsen, Ragnar
    Juergens, Gesche
    [J]. AAPS JOURNAL, 2020, 22 (06):
  • [33] Pulmonary administration of remdesivir in the treatment of COVID-19
    Henrik Berg Rasmussen
    Peter Riis Hansen
    Olivier Taboureau
    Ragnar Thomsen
    Gesche Jürgens
    [J]. The AAPS Journal, 22
  • [34] Remdesivir and COVID-19
    Francesco Ferrara
    Raffaele La Porta
    Vilma D’Aiuto
    Antonio Vitiello
    [J]. Irish Journal of Medical Science (1971 -), 2021, 190 : 1237 - 1238
  • [35] On the molecular structure of Remdesivir for the treatment of Covid-19
    Sheikholeslami, S. M.
    Jahanbani, A.
    Shao, Z.
    [J]. COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2021, 24 (09) : 995 - 1002
  • [36] Remdesivir in covid-19
    Ferner, Robin E.
    Aronson, Jeffrey K.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [37] Remdesivir and COVID-19
    Edwards, Jessie K.
    Cole, Stephen R.
    Adimora, Adaora A.
    [J]. LANCET, 2020, 396 (10256): : 953 - 953
  • [38] Remdesivir and COVID-19
    Ferrara, Francesco
    La Porta, Raffaele
    D'Aiuto, Vilma
    Vitiello, Antonio
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1237 - 1238
  • [39] Fully publishing the Approval Study of Remdesivir for the Treatment of Patients with COVID-19
    Klein, Friederike
    [J]. PNEUMOLOGIE, 2021, 75 (02): : 86 - 86
  • [40] Safety outcomes of Remdesivir for treatment of COVID-19 hospitalised patients in Indonesia
    Hasmono, Didik
    Samirah, Samirah
    Hartono, Ruddy
    Subkhan, Mohammad
    Yoshida, Maria Angelia
    Leliga, Fenny Kesuma
    [J]. PHARMACY EDUCATION, 2024, 24 (03): : 348 - 352
12345